heme has been researched along with Cognition Disorders in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (66.67) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fedin, AI; Karalkin, AV; Kholopova, EA; Kunitsyn, NV; Kuznetsov, MR; Virganskii, AO; Yumin, SM | 1 |
| Bel'skaya, GN; Derev'yannykh, EA; Knoll, EA; Krylova, LG; Popov, DV | 1 |
| Bugrova, SG | 1 |
| Guekht, A; Korczyn, AD; Skoog, I | 1 |
| Lidsky, TI; Schneider, JS | 1 |
| Buchanan, LH; Counter, SA; Ortega, F | 1 |
2 review(s) available for heme and Cognition Disorders
| Article | Year |
|---|---|
Neuroprotection in vascular dementia: a future path.
Topics: Animals; Cognition Disorders; Dementia, Vascular; Forecasting; Heme; Humans; Neuroprotective Agents; Risk Factors | 2012 |
Lead neurotoxicity in children: basic mechanisms and clinical correlates.
Topics: Apoptosis; Bone and Bones; Brain; Calcium Signaling; Child; Child, Preschool; Cognition Disorders; Environmental Exposure; Female; Genetic Predisposition to Disease; Heme; Humans; Infant; Lead; Lead Poisoning, Nervous System, Childhood; Maternal Exposure; Maximum Allowable Concentration; Neuroglia; Neurotransmitter Agents; Pregnancy; Prenatal Exposure Delayed Effects; Social Class | 2003 |
1 trial(s) available for heme and Cognition Disorders
| Article | Year |
|---|---|
[Efficacy of actovegin in the treatment of cognitive disturbances in discirculatory encephalopathy].
Topics: Aged; Aged, 80 and over; Brain; Brain Ischemia; Central Nervous System Stimulants; Cerebrovascular Circulation; Cognition Disorders; Drug Therapy; Female; Heme; Humans; Male; Middle Aged; Neuropsychological Tests; Severity of Illness Index | 2008 |
3 other study(ies) available for heme and Cognition Disorders
| Article | Year |
|---|---|
[Pharmacological preconditioning in carotid endarterectomy].
Topics: Aged; Antioxidants; Brain Ischemia; Carotid Stenosis; Cerebrovascular Circulation; Cerebrovascular Disorders; Chemotherapy, Adjuvant; Cognition Disorders; Endarterectomy, Carotid; Female; Heme; Humans; Male; Middle Aged; Postoperative Complications; Preoperative Period; Tomography, Emission-Computed, Single-Photon; Treatment Outcome | 2015 |
Experience in the use of Actovegin in the treatment of patients with cognitive disorders in the acute period of stroke.
Topics: Aged; Brain Ischemia; Central Nervous System Stimulants; Cerebral Infarction; Cerebrovascular Circulation; Cognition Disorders; Electroencephalography; Female; Heme; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neuropsychological Tests; Nootropic Agents; Piracetam; Stroke; Tomography, X-Ray Computed | 2008 |
Zinc protoporphyrin levels, blood lead levels and neurocognitive deficits in Andean children with chronic lead exposure.
Topics: Adolescent; Case-Control Studies; Child; Cognition; Cognition Disorders; Ecuador; Environmental Exposure; Female; Heme; Humans; Lead; Lead Poisoning, Nervous System, Childhood; Male; Protoporphyrins; Time Factors | 2008 |